MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6603-522-529$20.00
Mol Pharmacol 66:522-529, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Funicello, M.
Right arrow Articles by Gobbi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Funicello, M.
Right arrow Articles by Gobbi, M.

Dissociation of [3H]L-Glutamate Uptake from L-Glutamate-Induced [3H]D-Aspartate release by 3-Hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic Acid and 3-Hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic Acid, Two Conformationally Constrained Aspartate and Glutamate Analogs

Marcella Funicello, Paola Conti, Marco De Amici, Carlo De Micheli, Tiziana Mennini, and Marco Gobbi

Istituto di Ricerche Farmacologiche "Mario Negri", Milano, Italy (M.F., T.M., M.G.) and Istituto di Chimica Farmaceutica e Tossicologica, Università di Milano, Milano Italy (P.C., M.DeA., C.DeM.)

We characterized the interaction of two conformationally constrained aspartate and glutamate analogs, 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid (HIP-A) and 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic acid (HIP-B), with excitatory amino acid transporters (EAATs) in rat brain cortex synaptosomes. HIP-A and HIP-B were potent and noncompetitive inhibitors of [3H]L-glutamate uptake, with IC50 values (17–18 µM) very similar to that of the potent EAAT inhibitor DL-threo-{beta}-benzyloxyaspartic acid (TBOA). The two compounds had little effect in inducing [3H]D-aspartate release from superfused synaptosomes but they potently inhibited L-glutamate–induced [3H]D-aspartate release, thus behaving as EAAT blockers, not substrates, in a manner similar to those of TBOA and dihydrokainate (DHK). HIP-A and HIP-B, but not TBOA and DHK, unexpectedly inhibited L-glutamate–induced [3H]D-aspartate release with IC50 values (1.2–1.6 µM) 10 times lower than those required to inhibit [3H]L-glutamate uptake. There is therefore a concentration window (1–3 µM) in which the two compounds significantly inhibited L-glutamate–induced release with very little effect on L-glutamate uptake. This selective inhibitory effect required quite long preincubation (>5 min) of synaptosomes with the drugs. At these low concentrations, however, HIP-A and HIP-B had no effect on the EAAT-mediated [3H]D-aspartate release induced by altering the ion gradients, indicating that they specifically affect some L-glutamate-triggered process(es)—different from L-glutamate translocation itself—responsible for the induction of reverse transport. These data are inconsistent with the classic model of facilitated exchange-diffusion and provide the first evidence that EAAT-mediated substrate uptake and substrate-induced EAAT-mediated reverse transport are independent. Compounds such as HIP-A and HIP-B could be useful to further clarify the mechanisms underlying these operating modes of transporters.


Received December 22, 2003; accepted May 21, 2004

Address correspondence to: Marco Gobbi, Istituto di Ricerche Farmacologiche "Mario Negri", 20157 Milano, Italy. E-mail: gobbi{at}marionegri.it




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y.-J. I. Jong, V. Kumar, A. E. Kingston, C. Romano, and K. L. O'Malley
Functional Metabotropic Glutamate Receptors on Nuclei from Brain and Primary Cultured Striatal Neurons: ROLE OF TRANSPORTERS IN DELIVERING LIGAND
J. Biol. Chem., August 26, 2005; 280(34): 30469 - 30480.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics